awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33627312-C166F0E8-D795-42D2-9A89-C6E850D3C66B
Q33627312-C166F0E8-D795-42D2-9A89-C6E850D3C66B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33627312-C166F0E8-D795-42D2-9A89-C6E850D3C66B
Phase 1 study of marizomib in relapsed or relapsed and refractory multiple myeloma: NPI-0052-101 Part 1
P2860
Q33627312-C166F0E8-D795-42D2-9A89-C6E850D3C66B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33627312-C166F0E8-D795-42D2-9A89-C6E850D3C66B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a5e8cbf4785389605df14e91466415ddae113513
P2860
Incidence and management of adverse events in patients with relapsed and/or refractory multiple myeloma receiving single-agent carfilzomib